Oncologist Segmentation: How Virtual Engagement Can be Tailored Based on Attitudes and Preferences

Three Prominent and Differentiated Oncologist Attitudinal Segments Which Can Be Typed for Enhanced Engagement Opportunities

The COVID-19 pandemic has made evident the need to conduct research with the oncologist treater community to better understand their attitudes and outlook toward virtual versus in-person industry engagement. Through our research we have uncovered three key segments that explain how pharmaceutical companies can engage with oncologists throughout the pandemic and in growing opportunities for virtual interactions.